Steroid-Induced Changes of Eosinophils in Atopic Dermatitis

International Archives of Allergy and Immunology

Volumn 114, Issue 1, 1997, Pages 51-54

  Matsukura, Masaharu ^a   Yamada, Hidekazu ^a   Yudate, Tatsuo ^a   Tezuka, Tadashi ^a   Chihara, Junich ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Atopic dermatitis; Eosinophil; Steroid; Survival rate

Indexed keywords

CORTICOSTEROID; RECOMBINANT INTERLEUKIN 5; STEROID;

APOPTOSIS; ATOPIC DERMATITIS; BLOOD CELL COUNT; CELL CULTURE; CELL SURVIVAL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EOSINOPHIL; EOSINOPHILIA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILIA; EOSINOPHILS; GLUCOCORTICOIDS; HUMANS; PREDNISOLONE;

EID: 0030722488     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237718     Document Type: Article

References (18)

1. Rajka G: Atopic dermatitis. Major problems in dermatology, edited by A Rock. Saunders, London, 1975, pp 42-45.
2. Fukuda T, Gleich GJ: Heterogeneity of human eosinophils. J Allergy Clin Immunol 1989;83: 369-373.
3. Paganelli R, Fanalcs-Bclasio E, Carmini D, Scala E, Meglio P, Businco L, Aiuti F: Serum eosinophil cationic protein in patients with atopic dermatitis. Int Arch Allergy Appi Immunol 1991;96:175-178.
4. Wasson DL, Loegering DA, Solley GO, Moore SB, Schoorly RT, Fauci AS, Gleich GJ: Elevated serum levels of the eosinophil granule major basic protein in patients with eosino-philia. J Clin Invest 1981;67:651-661.
5. Czech W, Krutmann J, Schopf E, Kapp A: Scrum eosinophil cationic protein (ECP) is a sensitive measure for diesease activity in atopic dermatitis. Br J Dermatol 1992;126:351-355.
6. Leifcrman KM: Eosinophils in atopic dermatitis. Allergy 1989;44(suppl 9):20-26.
7. Liefcrman KM, Ackerman SJ, Sampson HA, Haugen HS, Venencic PY, Gieich GJ: Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med 1985;313:282-285.
8. Matsukura M, Yamada H, Yudate T, Chihara J, Tczuka T: Corticosteroid induced apoptosis of eosinophils in atopic dermatitis patients. J Clin Lab Immunol 1996;48:109-122.
9. Chihara J, Kurachi D, Yamamoto T, Yamada H, Wada T, Yasukawa A, Nakajima S: A comparative study of eosinophil isolation by different procedures of CD 16-negative depletion. Allergy 1995;50:11-14.
10. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980:284:555-556.
11. Hallsworth MP, Lichtficld TM, Lee TH: Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 1992;75:382-385.
12. Wallen N, Kita H, Weiler D, Gleich GJ: Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991 : 147:3490-3495.
13. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: Intcrleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-2547.
14. Stern M, Meagher L, Savill J, Haslctt C: Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992;148:3543-3549.
15. Lamas AM, Leon OG, Schleimer RP: Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 1991;147:254-259.
16. Brown DG, Sun XM, Cohen GM: Dexametha-sone-induced apoptosis involves cleavage of DNA to large fragments prior to intemuclcoso-mal fragmentation. J Biol Chem 1993;268: 3037-3039.
17. Beutler B, Krochin N, Milsark IW, Luedke C, Ccrami A: Control ofcachcctin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 1986;232:977-980.
18. Yamaguchi Y, Hayashi Y, Sugawa Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T: High purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chcmotactic factor. J Exp Med 1988;167:1737-1742.